‘Nirmacom’

WHO prequalifies Hetero’s generic version of the COVID-19 oral medication ‘Nirmacom’

The biggest pharmaceutical business in India, Hetero, announced that its generic version of COVID-19 oral antiviral therapy candidate nirmatrelvir has…

Read More »